Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03ZPX
|
||||
Former ID |
DIB009459
|
||||
Drug Name |
PRX-07034
|
||||
Synonyms |
5-HT 6 antagonists (obesity/cognitive impairment), EPIX; 5-HT 6 antagonists (obesity/cognitive impairment), Predix
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Obesity [ICD9: 278; ICD10:E66] | Phase 1 | [1] | ||
Company |
Epix Pharmaceutical
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C21H29Cl2N3O4S
|
||||
Canonical SMILES |
c1c(c(c(cc1Cl)C(C)Nc1c(ccc(c1)N1CCNCC1)S(=O)(=O)C)OC)OC<br />.Cl
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 6 receptor | Target Info | Antagonist | [2] | |
KEGG Pathway | Calcium signaling pathway | ||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Serotonergic synapse | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
PathWhiz Pathway | Excitatory Neural Signalling Through 5-HTR 6 and Serotonin | ||||
Reactome | Serotonin receptors | ||||
G alpha (s) signalling events | |||||
WikiPathways | Serotonin Receptor 4/6/7 and NR3C Signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021329) | ||||
REF 2 | Low-dose prazosin in combination with 5-HT6 antagonist PRX-07034 has antipsychotic effects. Can J Physiol Pharmacol. 2015 Jan;93(1):13-21. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.